JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Premature Ejaculation and Erectile Dysfunction in Iranian Prostate Cancer Patients
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Premature Ejaculation and Erectile Dysfunction in Iranian Prostate Cancer Patients
Lin, Chung-Ying; Burri, Andrea; Pakpour, Amir H;
  PDF(new window)
 Abstract
Background: To investigate the prevalence of premature ejaculation (PE) and erectile dysfunction (ED) in a sample of patients with prostate cancer and to determine the utility of the previously suggested cutoffs of the Premature Ejaculation Diagnostic Tool (PEDT) for the diagnosis of PE and that of International Index of Erectile Function (IIEF-5) for ED. Materials and Methods: A total of 1,202 men with prostate cancer were invited from urology clinics at the universities of Iran, Tehran, Qazvin, Ahvaz, Guilan and Tabriz. Clinical characteristics were collected through medical records. PE and ED diagnoses were made by trained urologists. In addition to the clinical diagnoses, PE and ED were measured through self-report using the PEDT and the IIEF-5. Questionnaire cutoff scores were determined using receiver operating characteristic (ROC) curves and confirmed by predictive ability using logistic regression. Results: The prevalence of PE was 63.7% and that of ED was 66.2%. Prevalences of PE decreased and that of ED increased with advanced TNM stages. According to ROC, the suggested cutoff for the PEDT to diagnose a PE was (sensitivity
 Keywords
Erectile dysfunction;prostate cancer;premature ejaculation;prevalence;PEDT;IIEF-5;
 Language
English
 Cited by
 References
1.
Aus G, Abbou CC, Bolla M, et al (2005). EAU guidelines on prostate cancer. Eur Urol, 48, 546-51. crossref(new window)

2.
Beard CJ, Lamb C, Buswell L, et al (1998). Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys, 41, 257-62. crossref(new window)

3.
Benson CR, Serefoglu EC, Hellstrom WJ (2012). Sexual dysfunction following radical prostatectomy. J Androl, 33, 1143-54. crossref(new window)

4.
Bianco FJ, McHone BR, Wagner K, et al (2009). Prevalence of erectile dysfunction in men screened for prostate cancer. Urol, 74, 89-93. crossref(new window)

5.
Bodie J, Lewis J, Schow D, et al (2003). Laboratory evaluations of erectile dysfunction: an evidence based approach. J Urol, 169, 2262-4 crossref(new window)

6.
Bortolotti A, Fedele D, Chatenoud L, et al (2001). Cigarette smoking: a risk factor for erectile dysfunction in diabetics. Eur Urol, 40, 392-6. crossref(new window)

7.
Chen RC, Vetter RJ, Lukka H, et al (2014). Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. J Natl Cancer Inst, 106, 132. crossref(new window)

8.
Choo R, Long J, Gray R, et al (2010). Prospective survey of sexual function among patients with clinically localized prostate cancer referred for definitive radiotherapy and the impact of radiotherapy on sexual function. Support Care Cancer,18, 715-22.

9.
Chew KK, Bremner A, Stuckey B, et al (2009). Is the relationship between cigarette smoking and male erectile dysfunction independent of cardiovascular disease? Findings from a population-based cross-sectional study. J Sex Med, 6, 222-31. crossref(new window)

10.
Dubbelman YD, Dohle GR, Schröder FH (2006). Sexual function before and after radical retropubic prostatectomy: a system review of prognostic indicators for a successful outcome. Eur Urol, 50, 711-18. crossref(new window)

11.
DSM-5: Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington (DC): American Psychiatric Association; 2013

12.
Diagnostic and statistical manual of mental disorders, fourth edition, text revision: DSM-IV-TR. Washington (DC): American Psychiatric Association; 2000.

13.
Fan J, Upadhye S, Worster A (2006). Understanding receiver operating characteristic (ROC) curves. CJEM 2006,8,19-20.

14.
Gallo L, Perdona S, Gallo A (2010). The role of short frenulum and the effects of frenulectomy on premature ejaculation. J Sex Med, 7, 1269-76. crossref(new window)

15.
Gagnon DD, Polverejan E (2008). Premature Ejaculation: results from a five-country European observational study. Eur Urol, 53, 1048-57. crossref(new window)

16.
Giuliano F, Patrick DL, Porst H, et al (2014). Female partner's perception of premature ejaculation and its impact on relationship breakups, relationship quality, and sexual satisfaction. J Sex Med, 11, 2243-55. crossref(new window)

17.
Incrocci L, Slob AK, Levendag PC (2002). Sexual (dys)function after radiotherapy for prostate cancer: a review. Int J Radiat Oncol Biol Phys, 52, 681-93. crossref(new window)

18.
Ong WL, McLachlan H, Millar JL (2015). Prevalence of baseline erectile dysfunction (ED) in an Australian cohort of men with localized prostate cancer. J Sex Med, 12, 1267-74. crossref(new window)

19.
Pakpour AH, Yekaninejad MS, Nikoobakht MR, et al (2014). Psychometric properties of the Iranian version of the Premature Ejaculation Diagnostic Tool. Sex Med, 2, 31-40. crossref(new window)

20.
Pakpour AH, Zeidi IM, Yekaninejad MS, et al (2014). Validation of a translated and culturally adapted Iranian version of the International Index of Erectile Function. J Sex Marital Ther, 40, 541-51. crossref(new window)

21.
Rosen RC, Cappelleri JC, Smith MD et al (1999). Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res, 11, 319-26. crossref(new window)

22.
Saitz TR, Serefoglu EC, Trost LW et al (2013). The pre-treatment prevalence and types of sexual dysfunction among patients diagnosed with prostate cancer. Androl, 1, 859-63. crossref(new window)

23.
Spector IP, Carey MP (1990). Incidence and prevalence of sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav, 19, 389-408. crossref(new window)

24.
Singer PA, Tasch ES, Stocking C, et al (1991). Sex or survival: tradeoffs between quality and quantity of life. J Clin Oncol, 9, 328-34. crossref(new window)

25.
Symonds T, Perelman MA, Althof S, et al (2007). Development and validation of a premature ejaculation diagnostic tool. Eur Urol, 52, 565-73. crossref(new window)

26.
Waldinger MD, Zwinderman AH, Schweitzer DH, et al (2004). Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res, 16, 369-81. crossref(new window)

27.
Walz J, Perrotte P, Suardi N, et al (2008). Baseline prevalence of erectile dysfunction in a prostate cancer screening population. J Sex Med, 5, 428-35. crossref(new window)